Work environment influence on cytostatics-induced genotoxicity in oncologic nurses

American Journal of Industrial Medicine

Volumn 30, Issue 1, 1996, Pages 67-71

  Brumen, Vlatka ^a   Horvat, Djurdja ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

chromosomal damage; cytostatics; genotoxicity; oncologic nurses; work environment

Indexed keywords

CYTOSTATIC AGENT;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; FEMALE; GENOTOXICITY; HEALTH HAZARD; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NURSE; OCCUPATIONAL EXPOSURE; STATISTICAL ANALYSIS; WORKPLACE;

ADULT; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHROMOSOMES; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GENES; HUMANS; INCIDENCE; METHOTREXATE; OCCUPATIONAL EXPOSURE; ONCOLOGIC NURSING; PROTECTIVE DEVICES; SAFETY; SISTER CHROMATID EXCHANGE; VINCRISTINE; WORKPLACE;

EID: 0029757741     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0274(199607)30:1<67::AID-AJIM11>3.0.CO;2-6     Document Type: Article

References (32)

1. American Society of Hospital Pharmacists. (1990): ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm 47:1033-1049.
2. Anwar WA, Salama SI, El Serafy MM, Hemida SA, Hafez AS. (1994): Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs. Mutagenesis 9:315-317.
3. Brier K, Latiolais C, Scheider P (1981): Effect of laminar air-flow and cleanroom dress on contamination rates of intravenous admixtures. Am J Hosp Pharm 38:1144-1147.
4. Brumen V (1993): Incidence of structural chromosomal aberrations and sister chromatid exchanges among medical personnel handling antineoplastic drugs. Radiol Oncol 27:125-131.
5. Brumen V, Horvat DJ (1992): A possible genotoxic effect of cytostatic drugs in occupationally exposed personnel. Arh Hig Rada Toksikol 43: 313-319 [in Croatian].
6. Brumen V, Horvat DJ, Trošić I (1995): Potential genotoxic risk related to simultaneous exposure to radionuclides and cytostatics. Am J Ind Med 27:871-876.
7. Cooke J, Williams J, Morgan RJ, Cooke P, Calvert RT (1991): Use of cytogenetic methods to determine mutagenetic changes in the blood of pharmacy personnel and nurses who handle cytotoxic agents. Am J Hosp Pharm 48:1199-1205.
8. deMeo MP, Mérono S, deBaille AD, Botta A, Laget M, Guiraud H, Duménil G (1995): Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials. Int Arch Occup Environ Health 66:363-368.
9. deWerk Neal A, Wadden RA, Chiou WL (1983): Exposure of hospital workers to airborne antineoplastic agents. Am J Hosp Pharm 40:597-601.
10. Frank JP, Williams RJ (1982): X-ray induction of persistent hypersensitivity to mutation. Science 216:307-308.
11. Fuchs J, Hengstler JG, Jung D, Hiltl G, Konietzko J, Oesch F (1995): DNA damage in nurses handling antineoplastic agents. Mutat Res 342:17-23.
12. Goloni-Bertolo EM, Tajara EH, Manzato AJ, Varella-Garcia M (1992): Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs. Int J Cancer 50:341-344.
13. Grummt T, Grummt HJ, Schott G (1993): Chromosomal aberrations in peripheral lymphocytes of nurses and physicians handling antineoplastic drugs. Mutat Res 302:19-24.
14. Husum B, Wulf HC, Niebuhr E (1982): Normal sister chromatid exchanges in oral contraceptive users. Mutat Res 103:161-164.
15. Jordan D, Patil S, Jochimsen P, Lachenbruch P, Corder M (1986): Sister chromatid exchange analysis in nurses handling antineoplastic drugs. Cancer Invest 4:101-107.
16. Kato H (1974): Spontaneous sister chromatid exchanges detected by BrdU-labeling method. Nature 252:70-72.
17. Knuutila S, Mäki-Paakkanen J, Kahkonen M, Hokkanen E (1978): An increased frequency of chromosomal changes in cultured blood lymphocytes of 12 subjects vaccinated against smallpox. Hum Genet 41:89-96.
18. Kurvink K, Bloomfield CD, Cervenka J (1978): Sister chromatid exchange in patients with viral disease. Exp Cell Res 113:450.
19. McDiarmid MA, Kolodner K, Humphrey F, Putman D, Jacobson-Kram D (1992): Baseline and phosphoramide mustard-induced sister-chromatid exchanges in pharmacists handling anti-cancer drugs. Mutat Res 279:199-204.
20. Milković-Kraus S, Horvat DJ (1991): Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs. Am J Ind Med 19:771-774.
21. Nikula E, Kivinitty K, Leisti J, Taskinen P (1984): Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scand J Work Environ Health 10:71-74.
22. Oestreicher U, Stephan G, Glatzel M (1990): Chromosome and SCE analysis in peripheral lymphocytes of persons occupationally exposed to cytostatic drugs handled with and without use of safety covers. Mutat Res 242:271-277.
23. Poyen D, deMeo MP, Botta A, Gouvernet J, Dumenil G (1988): Handling of cytostatic drugs and urine mutagenesis. Int Arch Occup Environ Health 61:183-188.
24. Rogers B (1987): Health hazards to personnel handling antineoplastic drugs. Occup Med 2:513-524.
25. Sachs L (1974): "Angewandte Statistik." Berlin: Springer-Verlag.
26. Sarto F, Trevisan A, Tomanin R, Canova A, Fiorentino M (1990): Chromosomal aberrations, sister chromatid exchanges and urinary thioethers in nurses handling antineoplastic drugs. Am J Ind Med 18:689-695.
27. Sessink PJM, Cerna M, Rössner P, Pastorkova A, Bavarova H, Frankova K, Anzion RBM, Bos RP (1994a): Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutat Res 309:193-199.
28. Sessink PJM, van de Kerkof MCA, Anzion RBM, Noordhoek J, Bos RP (1996b): Environmental contamination and assessment of cyclophosphamide in urine of exposed pharmacy technicians. Is skin absorption an important exposure route? Arch Environ Health in press.
29. Sorsa M, Hemminki K, Vainio H (1985): Occupational exposure to anticancer drugs. Potential and real hazards. Mutat Res 154:135-149.
30. Sotaniemi EA, Sutinen S, Arranto A (1983): Liver damage in nurses handling cytostatic agents. Acta Med Scand 214:181-189.
31. Stucker I, Hirsch A, Doloy T, Bastie-Sigeack I, Hemon D (1986): Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. Int Arch Occup Environ Health 57:195-205.
32. Venitt S, Crofton-Sleigh C, Hunt J, Speechley V, Briggs K (1984): Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: Urinary mutation assays and urinary platinum as markers of absorption. Lancet 1:74-77.